Latest News and Press Releases

Ottawa, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The global recycled engineering plastics market size is calculated at USD 5.09 billion in 2025 and is expected to be worth around USD 7.89 billion by 2034,...

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising. VANCOUVER, B.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- ESGold Corp. (CSE: ESAU | OTCQB: ESAUF |...

HUNTSVILLE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational...

Ottawa, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The global industrial enzymes market size was valued at USD 8.19 billion in 2024 and is anticipated to reach around USD 16.04 billion by 2034, growing at a...

- Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 -  - Sharpened focus on multi-modality pipeline with introduction of Voyager NeuroShuttle™ discovery...

Interim Phase 1 results for APG333 exceeded trial objectives, demonstrated a half-life of approximately 55 days, and suppressed key biomarkers for 6 months following a single dose, supporting...

Aligned with U.S Food and Drug Administration (FDA) on design of planned Phase 3 clinical trial of neflamapimod in patients with dementia with Lewy bodies (DLB) Reported 32-week data from Phase 2b...

–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – –...

Data rich period continues to support certepetide’s broad applicability and effectiveness Catalent enters into global license agreement for the use of certepetide as part of their SMARTag®...

-- Third quarter revenues up 6% driven by EXPAREL volume growth of 9% -- -- Several key milestones advance 5x30 path to growth and value creation -- -- Conference call today at 4:30 p.m. ET -- ...